About Jordan Sherwood, MD
Jordan Sherwood, MD, is a pediatric endocrinologist with particular interests in diabetes and diabetes technology. He completed pediatric residency at Massachusetts General Hospital for Children (MGHfC), and a fellowship in pediatric endocrinology at MGHfC. Dr. Sherwood is active in research with a focus on clinical trials of artificial pancreas technology for the management of diabetes. He has presented his work at regional, national and international forums.
Departments, Centers, & Programs:
Clinical Interests:
- Adrenal disorders
- Childhood obesity
- Diabetes
- Diabetes Mellitus Type 1
- Diabetes Mellitus Type 2
- Endocrinology
- Growth and nutritional disorders
- Pediatric endocrinology
- Pubertal disorders
- Thyroid disorders
Treats:
- Pediatrics
Locations
Mass General for Children: Pediatric Endocrine Program and Diabetes Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2909
Medical Education
- MD, University of Connecticut
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Pediatric Endocrinology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Sherwood JS, Balliro CA, Jafri RZ, El-Khatib FH, Maheno M, Hillard MA, O’Donovan JA, Selgamsetty R, Zheng H, Damiano ER, Russell SJ. Differential Effects of the Insulin-Only and Bihormonal Configurations of the Bionic Pancreas on Mean Glucose and Hypoglycemia During the Daytime and Nighttime. Diabetes 2018 Jul; 67(Supplement 1): doi: https://doi.org/10.2337/db18-299-OR
Sherwood JS, Balliro CA, Sloane JS, Jafri RZ, Putman MS, Russell SJ. Pilot Study of Closed-Loop Glycemic Control with the Bionic Pancreas in Cystic Fibrosis- Related Diabetes. Supplement: The 32nd Annual North American Cystic Fibrosis Conference, Oct 2019 Pediatric Pulmonology. 2018;53(S2):S1-S35. doi: doi:10.1002/ppul.24150.
Jafri, RZ, Balliro CA , Sherwood JS, Hillard MA, Ekhlaspour, L, Hsu L, Selagamsetty R, Costik J, Sloane JL, Buckingham BA , El-Khatib FH, Damiano ER, ,Russell, SJ.. First Human Study Testing the iLet, a Purpose-Built Bionic Pancreas Platform. American Diabetes Association 79th Scientific Sessions. Diabetes 2019 Jun; 68 (Supplement 1): 77-OR. https://doi.org/10.2337/db19-77-OR
Sherwood JS, Balliro CA, El-Khatib FH, Ekhlaspour L, Hsu L, Buckingham BA, Damiano ER, Russell SJ. Automated Adaptation of the Bionic Pancreas While Transitioning from Multiple Daily Injection Insulin Regimens. American Diabetes Association 79th Scientific Sessions. Diabetes 2019 Jun; 68 (Supplement 1): 1053-P. https://doi.org/10.2337/db19-1053-P
Sherwood JS, Grennan KB, Hillard MA, El-Khatib FH, Damiano ER, Russell, SJ. Automated Glycemic Control with a Bionic Pancreas Configured for Use in the Critical-Care Setting. American Diabetes Association 79th Scientific Sessions. Diabetes 2019 Jun; 68 (Supplement 1): 78-OR. https://doi.org/10.2337/db19-78-OR